FDA Approved: SPIRONOLACTONE — Original Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved the Original Application (ANDA) for spironolactone from Zydus Lifesciences Limited, marking a generic version of the diuretic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Edema
• Heart Failure
• Hyperaldosteronism
• Hypertension
• Liver Cirrhosis
• Nephrotic Syndrome

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

ORIG AP for SPIRONOLACTONE (SPIRONOLACTONE)